With latest trials showing safety and efficacy in a candidate vaccine, GlaxoSmithKline is eager to take the next step toward preventing shingles across age groups.
With latest trials showing safety and efficacy in a candidate vaccine, GlaxoSmithKline is eager to take the next step toward preventing shingles across age groups.